Early stage IT and Healthcare Investing

Alvine Pharmaceuticals


company snapshot

Alvine Pharmaceuticals

Alvine Pharmaceuticals is dedicated to developing and commercializing therapeutics for the treatment of celiac sprue, a gluten-induced autoimmune disease for which no drug therapy is currently available. Celiac sprue is believed to affect as many as two million people in the U.S. alone, many of whom have suffered the symptoms of the disease but have not yet been diagnosed.

Follow The Company
Investment Team
Abhay Joshi, President & CEO
Facebook Google+ Twitter Email LinkedIn Share